Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 4, 2025

Salmon Market Set to Reach Valuation of US$ 51.20 Billion by 2033 | Astute Analytica

View original at globenewswire.com
Salmon Market Set to Reach Valuation of US$ 51.20 Billion by 2033 | Astute Analytica Chicago, Dec. 04, 2025 (GLOBE NEWSWIRE) -- The global salmon market was valued at US$ 25.19 billion in 2024 and is expected to reach US$ 51.20 billion by 2033, growing at a CAGR of 8.2% from 2025-2033…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • HoReCa (Hotels, Restaurants, Cafes) represents 70.52% of the market by end user

    80% confidence
  • Farmed salmon represents 76.24% of the market by fish type

    80% confidence
  • The Pure RAS bubble has officially burst following Atlantic Sapphire's collapse

    80% confidence
  • Europe represents 44.61% of the global salmon market in 2025, making it the largest region

    80% confidence
  • The global salmon market will grow from US$ 25.19 billion in 2024 to US$ 51.20 billion by 2033 at a CAGR of 8.2%

    80% confidence
  • Atlantic salmon represents 69.30% of the market by species

    80% confidence
  • Canned salmon represents 59.28% of the market by product type

    80% confidence
  • Chilean antibiotic usage (florfenicol) increased 22% in H1 2024 and full-year 2025 projections to combat Piscirickettsiosis

    80% confidence
  • The global salmon market is navigating its most volatile period in two decades

    80% confidence
  • Offshore aquaculture operations remain largely exempt from the 25% Resource Rent Tax

    80% confidence
  • Post-Smolt Strategy reduces sea-lice exposure by 50% and doubles license turnover

    80% confidence
  • Capital is fleeing Norwegian fjords to Iceland and Faroe Islands due to tax regime

    80% confidence
  • Offline distribution channels represent 61.08% of the market

    80% confidence
  • Up to 35% of Norwegian harvest was downgraded to Production Grade in Q1 due to Winter Ulcer crisis

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Salmon Market Set to Reach Valuation of US$ 51.20 Billion by 2033 | Astute Analytica — Source | Via News | Finance Via News